Risk Group Definition in Children with Acute Myeloid Leukemia by Calculating Individual Risk Factors on the Basis of a Multivariate Stepwise Cox Regression Analysis

References

• Cox D. R. Regression models and live-tables. Journal of the Royal Statistical Society 1972; 34: 187–220
   Google Scholar
• Creutzig U., Ritter J., Schellong G. Identification of two risk groups in childhood myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990; 75: 1932–1940
   PubMed Web of Science ®Google Scholar
• Creutzig U., Zimmermann M., Ritter J., Henze G., Graf N., Löffler H., Schellong G. Definition of a standard-risk group in children with AML. British Journal of Haematology 1999; 104: 630–639
   PubMed Web of Science ®Google Scholar
• Keating M. J., Smith T. L., Kantarjian H., Cork A., Walters R., Trijillo J. M., McCredie K. B., Gehan E. A., Freireich E. J. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia 1988; 2: 403–412
   PubMed Web of Science ®Google Scholar
• Wheatley K., Burnett A. K., Goldstone A. H., Gray R. G., Hann I. M., Harrison C. J., Rees J. K., Stevens R.E, Walker H. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. British Journal of Haematology 1999; 107: 69–79
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. British Journal of Haematology 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Annals of Internal Medicine 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Creutzig U., Harbott J., Sperling C., Ritter J., Zimmermann M., Löffler H., Riehm H., Schellong G., Ludwig W. D. Clinical significance of surface antigen expression in children with acute myeloid leukemia: result of study AML-BFM-87. Blood 1995; 86: 3097–3108
   PubMed Web of Science ®Google Scholar
• Hermann J., Plenert W., Zintl F., Fuchs D., Malke H., Dörffel W., Eggers G., Exadaktylos P., Hilgenfeldt E., Kotte W., Krause I., Kunert W., Mahal K. H., Mittler U., Potel S., Reddemann H., Rönisch P.S., Weinmann G. Improved treatment results in childhood acute nonlymphoblastic leukemia with the BFM-AML protocol 78 in a multicenter study in the GDR. Haematology and Blood Transfusion 1987; 30: 76–82
   PubMedGoogle Scholar
• Hermann J., Zintl F., Krause M., Palme H., Fuchs D., Prager J., Dörffel W., Domula M., Eggers G., Exadaktylos P., Kotte W., Krause I., Kunert W., Mittler U., Möbius D., Reddemann H., Siegert E., Weinmann G. Therapie der akuten myeloischen Leukämie bei Kindem—Ergebnisse der multizentrischen Therapiestudie AML II/87. Kinderärztliche Praxis 1991; 59: 321–327
   PubMedGoogle Scholar
• Coldman A. J., Elwood J. M. Examining survival data. CMA Journal 1979; 121: 1065–1071
   PubMed Web of Science ®Google Scholar
• Chang M., Raimondi S. C., Ravindranath Y., Carroll A. J., Camitta B., Gresik M. V., Steuber C. P., Weinstein H. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. Leukemia 2000; 14: 1201–1207
   PubMed Web of Science ®Google Scholar
• Sanz M. A., Martin G., Rayon C., Esteve J., Gonzalez M., Diaz-Mediavilla J., Bolufer P., Barragan E., Terol M. J., Gonzalez J. D., Colomer D., Chillon C., Rivas C., Gomez T., Ribera J. M., Bornstein R., Roman J., Calasanz M. J., Arias J., Alvarez C., Ramos F., Deben G. A modified AIDA protocol with anthracycyline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR alpha-positive acute promyelocytic leukemia. Blood 1999; 94(9)3015–3021
   PubMed Web of Science ®Google Scholar
• Hongeng S., Krance R. A., Bowman L. C., Srivastava D. K., Cunningham J. M., Horwitz E. M., Brenner M. K., Heslop H. E. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 13: 767–771
   Web of Science ®Google Scholar
• Davies S. M., Wagner J. E., Weisdorf D. J., Shu X. O., Blazar B. R., Enright H., McGlave P. B., Ramsay N. K. Unrelated donor bone marrow transplantation for hematological malignancies-current status. Leukemia and Lymphoma 1996; 23: 221–226
   PubMed Web of Science ®Google Scholar